World CB & CDx Summit Japan

Meet the ARC Team at World CDx Japan

19–20 May 2026 | Japan
Booth 5 | David Ribeiro speaking Wednesday 20 May at 9:00 AM

Will you be attending World CDx Japan this May?

The ARC team will be there from Tuesday 19 May to Wednesday 20 May 2026, meeting with partners and industry colleagues to discuss how ARC’s Regulatory, Pharma Tech and Laboratory services can support diagnostic, clinical trial and companion diagnostic programmes.

Why meet with ARC?

ARC Laboratory has received formal confirmation from the UK MHRA that, due to our Northern Ireland location, we can self-designate to enable testing of both EU and UK clinical trial samples under the IVDR Health Institution Exemption, Article 5(5).

This means eligible studies can avoid the need for a separate IVDR Performance Study application or Competent Authority approval.

What this means for your studies

• Faster study start-up
• Reduced regulatory burden
• Greater flexibility as assays evolve across EU and UK programmes

Meet the ARC team

David Ribeiro
Chief Operating Officer & Laboratory Director, ARC Research Laboratories
David brings extensive experience across large and small pharma, including 10 years leading an IVD company in clinical research.

James Lappin
Associate Director, Global Regulatory Compliance, ARC Regulatory
James will also be attending World CDx Japan and available to meet with partners and industry colleagues.

David will be speaking at World CDx Japan on Wednesday 20 May at 9:00 AM.

Book a meeting

If you’re attending World CDx Japan, book a short meeting with David to discuss how the ARC team could support your test, trial, or study.